The Utility of Serum Progesterone and Inhibin A for Monitoring Natural-Cycle IVF-ET
Open Access
- 1 January 1998
- journal article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 15 (9) , 538-541
- https://doi.org/10.1023/a:1022530103330
Abstract
Purpose: Our purpose was to assess the value of monitoring serum P and inhibin A to determine how values might improve the clinical monitoring of natural cycle in vitro fertilization (IVF)-embryo transfer (ET) patients. Methods: All patients (n = 26) who underwent natural-cycle IVF-ET (n = 35) were analyzed. Groups were evaluated according to patients who had a spontaneous luteinizing hormone (LH) surge (group I) and women receiving human chorionic gonadotropin (hCG) who underwent subsequent oocyte aspiration (group II). Group II was further evaluated according to women who did (n = 10) and did not (n = 7) have an ET. All cycles were evaluated with serial transvaginal ultrasonography and serum estradiol, progesterone, and inhibin A. When follicle maturity was achieved, hCG, 10,000 IU, was administered intramuscularly if a LH surge was not detected. Transvaginal ultrasound-guided aspiration was performed 34–36 hr after hCG administration followed by a 48-hr transcervical ET. Results: No differences were seen in cycles the day prior to (d-1) and the day of a spontaneous LH surge, (n = 18) or hCG (d-0)(n = 17) in group I or group II with respect to lead follicular diameter (d-1,15.3 ± 0.6 vs. 14.2 ± 0.9 mm; d-0, 17.4 ± 0.8 vs. 17.8 ± 0.6 mm) and serum estradiol (d-l, 148 ± 15 vs. 150 ± 15 pg/ml; d-0, 218 ± 15 vs. 199 ± 16 pg/ml), respectively. However, serum progesterone was significantly elevated in group I compared with group II on d-l (0.82 ± 0.6 vs. 0.48 ± 0.04 ng/ml; P < 0.05) and d-0 (1.1 ± 0.12 vs. 0.63 ± 0.08 ng/ml; P < 0.05). Inhibin A was significantly greater on d-l in group I (24 ± 2.5 vs. 15 ± 2.2 pg/ml; P < 0.05). In group II, cycles that resulted in an ET (n = 10) compared with group II cycles that did not (n = 7) revealed a significant difference in serum progesterone (0.51 ± 0.05 vs. 0.7 ± 0.07 ng/ml; P < 0.05) and inhibin A (15 ± 2.5 vs. 37.3±5 pg/ml; P < 0.05) the day of hCG. Conclusions: The possible application of serum progesterone and inhibin A in managing natural-cycle IVF-ET is suggested. These assays may predict women who should be set up for egg retrieval, while canceling others in spite of the absence of an LH surge.Keywords
This publication has 14 references indexed in Scilit:
- The Utility of a Midcycle Follicle-Stimulating Hormone Boost in Addition to Human Chorionic Gonadotropin for Timing of Follicle Aspiration in Unstimulated in vitro Fertilization CyclesGynecologic and Obstetric Investigation, 1997
- In vitro fertilization in unstimulated cycles: the University of Southern California experienceFertility and Sterility, 1992
- In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology (SART), The American Fertility Society.1992
- In Vitro Fertilization in Unstimulated CyclesObstetrics & Gynecology, 1990
- In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cyclesFertility and Sterility, 1989
- Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrievalFertility and Sterility, 1989
- Ovarian hyperstimulation inhibits embryo implantation in the mouseJournal of Assisted Reproduction and Genetics, 1989
- Inhibins, Activins, and Follistatins: Gonadal Proteins Modulating the Secretion of Follicle-Stimulating HormoneEndocrine Reviews, 1988
- Circulating Immunoreactive Inhibin Levels During the Normal Human Menstrual Cycle*Journal of Clinical Endocrinology & Metabolism, 1987
- ESTABLISHING FULL‐TERM HUMAN PREGNANCIES USING CLEAVING EMBRYOS GROWN IN VITRO*BJOG: An International Journal of Obstetrics and Gynaecology, 1980